ArticleDiseases (Basel, Switzerland)2024

Impact of Ocrelizumab on Disease Progression, Memory Improvement, and Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis: A Longitudinal MRI and Clinical Criteria Analysis.

Amanda Claudia Schuldesz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.